Abstract
The discovery of cell-free fetal DNA in maternal plasma has offered new possibilities for non-invasive prenatal diagnosis and monitoring. The co-existence of fetal DNA as a minor fraction with a major background of maternal DNA in maternal plasma has posed a challenge for non-invasive prenatal detection of fetal chromosomal aneuploidies. The early approaches focus on the detection of fetal-specific RNA or DNA molecules to develop strategies for chromosome dosage determination, such as the RNA-single nucleotide polymorphism (SNP), epigenetic allelic ratio, and the epigenetic-genetic chromosome dosage approaches. While the detection of polymorphism is involved in these methods, a polymorphism-independent method has been developed with the highly precise digital polymerase chain reaction (PCR) platform. The power of single molecule counting technology is further demonstrated by the massively parallel sequencing platform for the direct detection of fetal chromosomal aneuploidies from maternal plasma. The analytical power of the latter approach with an unprecedented sensitivity, specificity, accuracy and precision has made it the most promising strategy for the clinical implementation of non-invasive prenatal diagnosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CV:
-
Coefficient of variation
- EAR:
-
Epigenetic allelic ratio
- EGG:
-
Epigenetic-genetic
- NIPD:
-
Non-invasive prenatal diagnosis
- PCR:
-
Polymerase chain reaction
- RCD:
-
Relative chromosome dosage
- SNP:
-
Single nucleotide polymorphism
- T18:
-
Trisomy 18
- T21:
-
Trisomy 21
References
Alberry M, Maddocks D, Jones M et al (2007) Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn 27:415–418
Benachi A, Yamgnane A, Olivi M et al (2005) Impact of formaldehyde on the in vitro proportion of fetal DNA in maternal plasma and serum. Clin Chem 51:242–244
Bianchi DW, Flint AF, Pizzimenti MF et al (1990) Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc Natl Acad Sci U S A 87:3279–3283
Bianchi DW, Simpson JL, Jackson LG et al (2002) Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn 22:609–615
Chan KCA, Zhang J, Hui AB et al (2004) Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 50:88–92
Chan KCA, Ding C, Gerovassili A et al (2006) Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 52:2211–2218
Chen XQ, Stroun M, Magnenat JL et al (1996) Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 2:1033–1035
Cheung MC, Goldberg JD, Kan YW (1996) Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood. Nat Genet 14:264–268
Chim SSC, Tong YK, Chiu RWK et al (2005) Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci U S A 102:14753–14758
Chim SSC, Jin S, Lee TYH et al (2008) Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. Clin Chem 54:500–511
Chinnapapagari SK, Holzgreve W, Lapaire O et al (2005) Treatment of maternal blood samples with formaldehyde does not alter the proportion of circulatory fetal nucleic acids (DNA and mRNA) in maternal plasma. Clin Chem 51:652–655
Chiu RWK, Lui WB, Cheung MC et al (2006) Time profile of appearance and disappearance of circulating placenta-derived mRNA in maternal plasma. Clin Chem 52:313–316
Chiu RWK, Chim SSC, Wong IH et al (2007) Hypermethylation of RASSF1A in human and rhesus placentas. Am J Pathol 170:941–950
Chiu RWK, Chan KCA, Gao Y et al (2008) Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 105:20458–20463
Chiu RWK, Cantor CR, Lo YMD (2009) Non-invasive prenatal diagnosis by single molecule counting technologies. Trends Genet 25:324–331
Chiu RWK, Sun H, Akolekar R et al (2010) Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. Clin. Chem 56:459–463
Chung GTY, Chiu RWK, Chan KCA et al (2005) Lack of dramatic enrichment of fetal DNA in maternal plasma by formaldehyde treatment. Clin Chem 51:655–658
Costa JM, Benachi A, Gautier E (2002) New strategy for prenatal diagnosis of X-linked disorders. N Engl J Med 346:1502
Daniels G, Finning K, Martin P et al (2009) Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects. Prenat Diagn 29:101–107
Dhallan R, Au WC, Mattagajasingh S, Emche S et al (2004) Methods to increase the percentage of free fetal DNA recovered from the maternal circulation. J Am Med Assoc 291:1114–1119
Dhallan R, Guo X, Emche S et al (2007) A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study. Lancet 369:474–481
Diehl F, Li M, Dressman D, He Y, Shen D et al (2005) Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci USA 102:16368–16373
Dohm JC, Lottaz C, Borodina T et al (2008) Substantial biases in ultra-short read data sets from high-throughput DNA sequencing. Nucleic Acids Res 36:e105
Dokras A, Gardner LM, Kirschmann DA et al (2002) The tumour suppressor gene maspin is differentially regulated in cytotrophoblasts during human placental development. Placenta 23:274–280
Fan HC, Quake SR (2007) Detection of aneuploidy with digital polymerase chain reaction. Anal Chem 79:7576–7579
Fan HC, Blumenfeld YJ, Chitkara U et al (2008) Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA 105:16266–16271
Ferguson-Smith MA (2003) Placental mRNA in maternal plasma: prospects for fetal screening. Proc Natl Acad Sci USA 100:4360–4362
Futscher BW, Oshiro MM, Wozniak RJ et al (2002) Role for DNA methylation in the control of cell type specific maspin expression. Nat Genet 31:175–179
Gahan PB, Swaminathan R (2008) Circulating nucleic acids in plasma and serum. Recent developments. Ann N Y Acad Sci 1137:1–6
Go AT, Visser A, Mulders MA et al (2007) 44 single-nucleotide polymorphisms expressed by placental RNA: assessment for use in noninvasive prenatal diagnosis of trisomy 21. Clin Chem 53:2223–2224
Grunau C, Clark SJ, Rosenthal A (2001) Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res 29:E
Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349:2042–2054
Heung MMS, Tsui NBY, Leung TY et al (2009) Development of extraction protocols to improve the yield for fetal RNA in maternal plasma. Prenat Diagn 29:277–279
Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128:683–692
Kopreski MS, Benko FA, Kwee C et al (1997) Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer. Br J Cancer 76:1293–1299
Korshunova Y, Maloney RK, Lakey N et al (2008) Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA. Genome Res 18:19–29
Li Y, Di Naro E, Vitucci A et al (2005) Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. J Am Med Assoc 293:843–849
Li M, Chen WD, Papadopoulos N et al (2009) Sensitive digital quantification of DNA methylation in clinical samples. Nat Biotechnol 27:858–863
Lo YMD, Chiu RWK (2007) Prenatal diagnosis: progress through plasma nucleic acids. Nat Rev Genet 8:71–77
Lo YMD, Corbetta N, Chamberlain PF et al (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350:485–487
Lo YMD, Hjelm NM, Fidler C et al (1998a) Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 339:1734–1738
Lo YMD, Tein MS, Lau TK et al (1998b) Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 62:768–775
Lo YMD, Lun FMF, Chan KCA et al (2007a) Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci USA 104:13116–13121
Lo YMD, Tsui NBY, Chiu RWK et al (2007b) Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 13:218–223
Lui YYN, Chik KW, Chiu RWK et al (2002) Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem 48:421–427
Lun FMF, Chiu RWK, Chan KCA et al (2008) Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem 54:1664–1672
Malone FD, Canick JA, Ball RH et al (2005) First-trimester or second-trimester screening, or both, for Down’s syndrome. N Engl J Med 353:2001–2011
Margulies M, Egholm M, Altman WE et al (2005) Genome sequencing in microfabricated high-density picolitre reactors. Nature 437:376–380
McKernan KJ, Peckham HE, Costa GL et al (2009) Sequence and structural variation in a human genome uncovered by short-read, massively parallel ligation sequencing using two-base encoding. Genome Res 19:1527–1541
McPherson JD (2009) Next-generation gap. Nat Methods 6:S2–S5
Nawroz H, Koch W, Anker P et al (1996) Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 2:1035–1037
Ng EKO, Tsui NBY, Lam NYL et al (2002) Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin Chem 48:1212–1217
Ng EKO, Tsui NBY, Lau TK et al (2003) mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci USA 100:4748–4753
Old RW, Crea F, Puszyk W et al (2007) Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome. Reprod Biomed Online 15:227–235
Ottesen EA, Hong JW, Quake SR et al (2006) Microfluidic digital PCR enables multigene analysis of individual environmental bacteria. Science 314:1464–1467
Oudejans CB, Go AT, Visser A et al (2003) Detection of chromosome 21-encoded mRNA of placental origin in maternal plasma. Clin Chem 49:1445–1449
Papageorgiou EA, Fiegler H, Rakyan V et al (2009) Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. Am J Pathol 174:1609–1618
Pohl G, Shih LM (2004) Principle and applications of digital PCR. Expert Rev Mol Diagn 4:41–47
Poon LLM, Leung TN, Lau TK et al (2000) Presence of fetal RNA in maternal plasma. Clin Chem 46:1832–1834
Poon LLM, Leung TN, Lau TK et al (2002) Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clin Chem 48:35–41
Qin J, Jones RC, Ramakrishnan R (2008) Studying copy number variations using a nanofluidic platform. Nucleic Acids Res 36:e116
Rakyan VK, Down TA, Thorne NP et al (2008) An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res 18:1518–1529
Ranke MB, Saenger P (2001) Turner’s syndrome. Lancet 358:309–313
Savva GM, Walker K, Morris JK (2010) The maternal age-specific live birth prevalence of trisomies 13 and 18 compared to trisomy 21 (Down syndrome). Prenat Diagn 30:57–64
Schuster SC (2008) Next-generation sequencing transforms today’s biology. Nat Methods 5:16–18
Tabor A, Philip J, Madsen M et al (1986) Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1:1287–1293
Tong YK, Ding C, Chiu RWK et al (2006) Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical and empirical considerations. Clin Chem 52:2194–2202
Tong YK, Jin S, Chiu RWK et al (2010) Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. Clin Chem 56:90–98
Tsui NBY, Ng EKO, Lo YMD (2002) Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem 48:1647–1653
Tsui NBY, Chim SSC, Chiu RWK et al (2004) Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling. J Med Genet 41:461–467
Tsui NBY, Wong BCK, Leung TY et al (2009) Non-invasive prenatal detection of fetal trisomy 18 by RNA-SNP allelic ratio analysis using maternal plasma SERPINB2 mRNA: a feasibility study. Prenat Diagn 29:1031–1037
Tsui NBY, Akolekar R, Chiu RWK et al (2010) Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21. Clin Chem 56:73–81
Voelkerding KV, Dames SA, Durtschi JD (2009) Next-generation sequencing: from basic research to diagnostics. Clin Chem 55:641–658
Vogelstein B, Kinzler KW (1999) Digital PCR. Proc Natl Acad Sci USA 96:9236–9241
Warren L, Bryder D, Weissman IL et al (2006) Transcription factor profiling in individual hematopoietic progenitors by digital RT-PCR. Proc Natl Acad Sci USA 103:17807–17812
Wong IHN, Lo YMD, Zhang J et al (1999) Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res 59:71–73
Yung TKF, Chan KCA, Mok TSK et al (2009) Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients. Clin Cancer Res 15:2076–2084
Zhou W, Galizia G, Lieto E et al (2001) Counting alleles reveals a connection between chromosome 18q loss and vascular invasion. Nat Biotechnol 19:78–81
Zhou W, Goodman SN, Galizia G et al (2002) Counting alleles to predict recurrence of early-stage colorectal cancers. Lancet 359:219–225
Zimmermann B, Holzgreve W, Wenzel F et al (2002) Novel real-time quantitative PCR test for trisomy 21. Clin Chem 48:362–363
Acknowledgement
The authors are supported by the University Grants Committee of the Government of the Hong Kong Special Administration Region, China – Areas of Excellence Scheme (AoE/M-04/06) and the Innovation and Technology Fund (ITS/054/09FP).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this paper
Cite this paper
Tong, Y.K., Chiu, R., Lo, Y. (2010). Circulating Fetal DNA/RNA in Maternal Plasma for Aneuploidy Detection. In: Gahan, P. (eds) Circulating Nucleic Acids in Plasma and Serum. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9382-0_16
Download citation
DOI: https://doi.org/10.1007/978-90-481-9382-0_16
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9381-3
Online ISBN: 978-90-481-9382-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)